GlassScriptPhysician profile
Maria I Rivera Sanchez
NPI 1588662860
$1,048.78
in general payments reported to CMS, 2019-2025
7 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.45 · 2021: $22.90 · 2022: $350 · 2023: $149 · 2024: $68.44 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.80 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $269.95 | 2022-2025 | Vabysmo |
| Allergan, INC. | $250.95 | 2019-2022 | |
| Abbvie INC. | $213.92 | 2023-2025 | |
| Bausch & Lomb Americas INC. | $142.84 | 2023-2025 | Miebo, Xiidra |
| Amgen INC. | $100.00 | 2025 | Pavblu |
| Alcon Vision LLC | $51.93 | 2024 | Clareon |
| Akorn, INC. | $19.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Rivera Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.